Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Possible teratogenicity of valproic acid.

× No keyword cloud information.

12 in total

Review 1. Clusters of birth defects: emergency and management. A review of some publications.

Authors: J Goujard
Journal: Eur J Epidemiol Date: 1999-10 Impact factor: 8.082

2. Patent ductus arteriosus in fetal valproate syndrome.

Authors: P Anoop; C K Sasidharan
Journal: Indian J Pediatr Date: 2003-08 Impact factor: 1.967

3. Monitoring and avoiding drug and chemical teratogenicity.

Authors: G Koren; S M MacLeod
Journal: CMAJ Date: 1986-11-15 Impact factor: 8.262

4. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors: W Fuhrmann; H K Weitzel
Journal: Hum Genet Date: 1985 Impact factor: 4.132

5. High-density single nucleotide polymorphism screen in a large multiplex neural tube defect family refines linkage to loci at 7p21.1-pter and 2q33.1-q35.

Authors: Demetra S Stamm; Evadnie Rampersaud; Susan H Slifer; Lorraine Mehltretter; Deborah G Siegel; Jianzhen Xie; Diane Hu-Lince; David W Craig; Dietrich A Stephan; Timothy M George; John R Gilbert; Marcy C Speer
Journal: Birth Defects Res A Clin Mol Teratol Date: 2006-06

6. Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats.

Authors: C V Vorhees
Journal: Psychopharmacology (Berl) Date: 1987 Impact factor: 4.530

7. Sodium valproate: effects on social behaviour and physical development in the mouse.

Authors: J B Chapman; M G Cutler
Journal: Psychopharmacology (Berl) Date: 1984 Impact factor: 4.530

8. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

Authors: E Thisted; F Ebbesen
Journal: Arch Dis Child Date: 1993-09 Impact factor: 3.791

9. Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect.

Authors: Orna Diav-Citrin; Svetlana Shechtman; Benjamin Bar-Oz; Dana Cantrell; Judy Arnon; Asher Ornoy
Journal: CNS Drugs Date: 2008 Impact factor: 5.749

10. Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in healthy male volunteers.

Authors: R H Düsing
Journal: Pharm Weekbl Sci Date: 1992-06-19